Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-20-257792
Filing Date
2020-09-29
Accepted
2020-09-29 16:00:52
Documents
1
Group Members
ARIX BIOSCIENCE HOLDINGS LTD

Document Format Files

Seq Description Document Type Size
1 SC 13D AMENDMENT NO.1 d10226dsc13da.htm SC 13D/A 68272
  Complete submission text file 0001193125-20-257792.txt   69776
Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Subject) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90696 | Film No.: 201208887
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 20 BERKELEY SQUARE LONDON X0 W1J 6EQ
Business Address 20 BERKELEY SQUARE LONDON X0 W1J 6EQ 44(0)20 7290 1050
Arix Bioscience plc (Filed by) CIK: 0001700449 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0
Type: SC 13D/A